what digital currency to buy- Top Featured

Spot gold just broke through the $2,710.00/oz mark, and the latest price was $2,709.91/oz, down 0.29% in the day; COMEX gold futures main force recently reported $2,744.30 per ounce, down 0.45% in the day.OPENAI said that it is working hard to solve the current fault problem.The Southern CSI A500ETF Link Fund was added with Y share, which was included in the list of individual pensions. Four products from southern fund were shortlisted for individual pensions, including the Southern CSI A500ETF Link Fund, and Y share was added with code 022918. Its target ETF-CSI A500ETF South (159352) has received a net inflow of funds for 38 consecutive days, with the latest scale approaching 19 billion yuan. According to the data of China Merchants Securities Fund Evaluation Center, in the past 10 years, South Stock ETF has been the most accurate in tracking, ranking first in its kind. Investors can borrow the layout of the A500ETF South (159352) and its linked funds (A 022434, C 022435, Y 022918).

Kweichow Moutai: The company will hold a briefing on the third quarter of 2024 from 15: 00 to 16: 00 on Tuesday, December 17, 2024.Piper Sandler lowered the target price of Adobe from 635.00 to 600.00.AIA Group repurchased 1.1 million shares for HK$ 61.7 million on December 12th.

AIA Group repurchased 1.1 million shares for HK$ 61.7 million on December 12th.CITIC Securities: The resonance between supply and demand of medical beauty accelerates the space expansion, and the difference in operating ability promotes the evolution of the industry structure. CITIC Securities Research Report stated that the medical beauty industry has both medical and consumption attributes, and the medical attribute has strong product-driven characteristics, while the consumption attribute has high operating ability requirements. The medical beauty botulinum toxin track is also affected by the dual attributes of medicine and consumption: 1) The increase in penetration rate, the acceleration of compliance substitution and the extension of indications have brought about high demand for medical beauty botulinum toxin, and with the recent supply expansion, the industry scale has experienced high growth; 2) The iteration of product innovation is slow, brand barriers are created through marketing, doctors are empowered through direct sales, and control is strengthened to enhance product competitiveness. Recently, a variety of medical botulinum toxins in China have been approved, and the promotion of low-priced products is expected to push up the penetration rate, and enterprises with strong operational capabilities will enter the market or promote the evolution of the pattern.Kweichow Moutai: The company will hold a briefing on the third quarter of 2024 from 15: 00 to 16: 00 on Tuesday, December 17, 2024.